Novo Nordisk A/S (NVO) News Today → weirdest stock market marches on (From DTI) (Ad) Free NVO Stock Alerts $131.89 -1.15 (-0.86%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 4:37 PM | marketbeat.comIndependent Advisor Alliance Increases Holdings in Novo Nordisk A/S (NYSE:NVO)Independent Advisor Alliance increased its stake in Novo Nordisk A/S (NYSE:NVO - Free Report) by 10.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 65,891 shares of the company's stockMay 18 at 6:51 PM | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Position Trimmed by Dillon & Associates Inc.Dillon & Associates Inc. lessened its holdings in Novo Nordisk A/S (NYSE:NVO - Free Report) by 3.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 274,008 shares of the company's stock after selling 8,469 shares during the quarter. NovMay 18 at 2:35 AM | fool.comIs Novo Nordisk Stock a Millionaire Maker?May 17 at 11:16 PM | marketbeat.comM. Kulyk & Associates LLC Buys New Shares in Novo Nordisk A/S (NYSE:NVO)M. Kulyk & Associates LLC bought a new stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 5,860 shares of the company's stock, valued at approximately $606,000. Several other large invMay 17 at 3:02 PM | investorplace.comPharma Stocks Outlook: Where Are 2024's Top Performers Headed Next?May 17 at 10:20 AM | globenewswire.comNovo Nordisk A/S - share repurchase programmeMay 16 at 6:30 PM | reuters.comNovo Nordisk building site hit by fire, Danish TV2 reportsMay 16 at 1:06 PM | finance.yahoo.comFire at Novo Nordisk Construction Site Gives Investors A ScareMay 16 at 1:06 PM | uk.finance.yahoo.comOzempic drives economic boom in Denmark as growth forecasts doubledMay 16 at 8:06 AM | uk.investing.comNovo Nordisk remains the most well-held European stock: Morgan StanleyMay 16 at 8:06 AM | yahoo.comDenmark Raises Growth Forecast as Novo Nordisk Expands OutputMay 16 at 7:15 AM | investorplace.com7 Pharma Stocks Harnessing AI Brainpower for Big BreakthroughsMay 16 at 6:15 AM | investorplace.comPatent Peril: 3 Stocks at Risk From the FTC's Drug CrusadeMay 15, 2024 | marketbeat.comJanney Montgomery Scott LLC Buys 15,392 Shares of Novo Nordisk A/S (NYSE:NVO)Janney Montgomery Scott LLC lifted its stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 5.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 305,178 shares of the company's stock after acquiring an additionalMay 15, 2024 | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Shares Up 0.4%Novo Nordisk A/S (NYSE:NVO) Shares Up 0.4%May 15, 2024 | finance.yahoo.comEli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And ZepboundMay 15, 2024 | finance.yahoo.comNo Wegovy Shortage in Denmark Amid High Demand, Novo Nordisk ConfirmsMay 15, 2024 | finance.yahoo.comNovo Nordisk Weigh-Loss Drugs Could Bankrupt US Health Care, Senate Committee Report SaysMay 15, 2024 | fool.comIf You'd Invested $1,000 in Novo Nordisk Stock 5 Years Ago, Here's How Much You'd Have TodayMay 15, 2024 | markets.businessinsider.comTD Cowen Reaffirms Their Buy Rating on Novo Nordisk (NVO)May 15, 2024 | globenewswire.comNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated personsMay 15, 2024 | fool.comNovo Nordisk Bets Up to $600 Million on Ozempic 2.0. Here's Why the Stock Is a Buy.May 15, 2024 | bloomberg.comNovo to Examine Alcohol Use in Liver Disease Treatment StudyMay 15, 2024 | finance.yahoo.comPRESS DIGEST- Financial Times - May 15May 15, 2024 | reuters.comNovo Nordisk owner buys majority stake in Austrian life science tools companyMay 15, 2024 | reuters.comNo shortage of Wegovy weight-loss drug in Denmark, Novo Nordisk saysMay 14, 2024 | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Shares Sold by Guardian Capital Advisors LPGuardian Capital Advisors LP reduced its stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 9.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 151,533 shares of the company's stock afterMay 14, 2024 | cnbc.comPeople on Novo Nordisk's Wegovy maintain weight loss for up to four years, study saysMay 14, 2024 | fool.com2 Top Pharma Stocks That Just Keep Getting Better and BetterMay 13, 2024 | reuters.comWegovy weight loss sustained for four years in trial, Novo Nordisk saysMay 13, 2024 | globenewswire.comNovo Nordisk A/S: Once-weekly and once-monthly Mim8 demonstrate superior reduction of treated bleeding episodes compared to on-demand and prior prophylaxis treatment in people with haemophilia A in the Frontier 2 trialMay 13, 2024 | reuters.comDenmark faces Wegovy shortage due to rising demand, medicines agency saysMay 13, 2024 | bloomberg.comOzempic Maker Novo Nordisk Plans Bond Sale to Fund ExpansionMay 13, 2024 | uk.finance.yahoo.com‘Outrageously’ expensive Ozempic should be cheaper, says Bernie SandersMay 13, 2024 | proactiveinvestors.comNovo Nordisk weight loss rollout to prompt ‘dramatic upgrades' - analystsMay 13, 2024 | marketbeat.comVictory Capital Management Inc. Sells 64,508 Shares of Novo Nordisk A/S (NYSE:NVO)Victory Capital Management Inc. lessened its position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 36.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 110,211 shares of the coMay 13, 2024 | msn.comSanders Urges Denmark to Pressure Novo Nordisk on Lowering Drug PricesMay 12, 2024 | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Shares Bought by King Wealth Management GroupKing Wealth Management Group lifted its position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 186.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 18,542 shares of the company's stock after buMay 12, 2024 | fool.comBillionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?May 11, 2024 | marketbeat.comQRG Capital Management Inc. Has $23.50 Million Position in Novo Nordisk A/S (NYSE:NVO)QRG Capital Management Inc. increased its holdings in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 15.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 227,175 shares of the company's stock afterMay 11, 2024 | fool.comWant Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.May 11, 2024 | marketbeat.comPrincipal Securities Inc. Makes New $2.81 Million Investment in Novo Nordisk A/S (NYSE:NVO)Principal Securities Inc. acquired a new stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 27,120 shares of the compaMay 9, 2024 | marketbeat.comArlington Capital Management Inc. Acquires Shares of 9,520 Novo Nordisk A/S (NYSE:NVO)Arlington Capital Management Inc. bought a new position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 9,520 shares of the company's stock, valued at apMay 9, 2024 | fool.com3 Million Reasons Novo Nordisk Still Looks Like a Phenomenal BuyMay 9, 2024 | finance.yahoo.comNovo Nordisk Sets Sights on a Long-Lasting Successor to Its Weight Loss BlockbusterMay 9, 2024 | reuters.comMetaphore Biotechnologies to partner with Novo Nordisk on obesity therapiesMay 9, 2024 | americanbankingnews.comNovo Nordisk A/S (NYSE:NVO) vs. Mallinckrodt (OTCMKTS:MNKKQ) Head to Head AnalysisMay 8, 2024 | marketbeat.comPatrick M Sweeney & Associates Inc. Invests $631,000 in Novo Nordisk A/S (NYSE:NVO)Patrick M Sweeney & Associates Inc. acquired a new stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,100 shares of the compaMay 8, 2024 | globenewswire.comNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated personsMay 7, 2024 | marketbeat.comEverpar Advisors LLC Buys New Stake in Novo Nordisk A/S (NYSE:NVO)Everpar Advisors LLC purchased a new position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 6,127 shares of the company's stock, valued at Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Free report reveals “two-baggers” for 2024 (Ad)We’ve put together something special for our subscribers — a free report on 5 stocks we believe could double in 2024. It’s straightforward, easy to understand, and most importantly, actionable. Download your free report today! NVO Media Mentions By Week NVO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVO News Sentiment▼0.560.42▲Average Medical News Sentiment NVO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVO Articles This Week▼3823▲NVO Articles Average Week Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Eli Lilly and Company News Today Johnson & Johnson News Today Merck & Co., Inc. News Today AbbVie News Today AstraZeneca News Today Novartis News Today Abbott Laboratories News Today Pfizer News Today UnitedHealth Group News Today Thermo Fisher Scientific News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVO) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressMost important medical advance in 100 yearsThe Oxford ClubUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingNext President (Not Trump. Not Biden.)The Freeport Society41 banks launch ‘crypto dollar’Stansberry ResearchWhat’s Really Next for America…Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
